Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Labeling errors & mix-ups

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose.

1,411 FDA drug recalls with this cause, newest first.

This is exactly what it sounds like: the wrong label on the right product, the wrong strength printed on the bottle, a missing or illegible lot number and expiry date, or two products mixed up during packaging. It is dangerous precisely because the pill or liquid itself may be fine, yet the patient has no way of knowing what they are actually taking. A high share of the Class I recalls in this group are mix-ups where a stronger product ended up in a weaker product's packaging.

Class I · High risk

Methocarbamol 500mg Tablet

Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets

Completed Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0092-2022
Class III · Low risk

Cetirizine hydrochloride

Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets.

Terminated Labeling / mix-up A-S Medication Solutions LLC. D-0096-2022
Class II · Moderate risk

The Natural Dentist Healthy Balance Peppermint Sage

Labeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Menthol with UPC 7 14132 00071 4 instead of Peppermint Oil and Sage Oil with UPC 7 14132 00073 8

Ongoing Labeling / mix-up Revive Personal Products Company D-0364-2022
Class III · Low risk

Butalbital

Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0257-2022
Class III · Low risk

Butalbital

Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label

Ongoing Labeling / mix-up Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals D-0256-2022
Class II · Moderate risk

Rocuronium Bromide Injection 50mg/5 mL

Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"

Terminated Labeling / mix-up Piramal Critical Care, Inc. NDC 66794-0228-41 D-0019-2022
Class II · Moderate risk

Kroger 70% Isopropyl Alcohol First Aid Antiseptic 32 FL OZ

Labeling: Label Mix-Up.The recall has been initiated after receiving one complaint about incorrect labeling.The primary label on the front and back label on some of the bottles have 70% Isopropyl Alcohol affixed to the containers. However, the product inside the bottle is Hydrogen Peroxide, Topical Solution USP with active ingredient Hydrogen Peroxide (stabilized) 3%, 32 FL Ounces

Terminated Labeling / mix-up Vi-Jon, Inc. NDC 30142-810-45 D-0799-2021
Class II · Moderate risk

Trulicity (dulaglutide)

Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.

Terminated Labeling / mix-up Eli Lilly & Company NDC 0002-1433-80 D-0773-2021
Class II · Moderate risk

Micafungin for Injection

Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.

Terminated Labeling / mix-up Xellia Pharmaceuticals USA, LLC NDC 70594-037-01 D-0757-2021
Class II · Moderate risk

Micafungin for Injection

Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.

Terminated Labeling / mix-up Xellia Pharmaceuticals USA, LLC NDC 70594-036-01 D-0756-2021
Class II · Moderate risk

Venlafaxine Tablets

Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg

Terminated Labeling / mix-up Sun Pharmaceutical Industries INC NDC 16714-657-01 D-0703-2021
Class I · High risk

Limar Hand Sanitizer

Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.

Ongoing Labeling / mix-up Ardil Comercial S.R.L. D-0691-2021
Class III · Low risk

Levetiracetam Tablets USP

Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

Terminated Labeling / mix-up McKesson Corporation dba McKesson Drug Company NDC 63739-795-10 D-0630-2021
Class I · High risk

1% Lidocaine HCl Injection

Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP

Terminated Labeling / mix-up Pfizer, INC NDC 0409-4279-16 D-0627-2021
Class I · High risk

0.5% Bupivacaine Hydrochloride Injection

Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP

Terminated Labeling / mix-up Pfizer, INC NDC 0409-1162-19 D-0626-2021
Class III · Low risk

Thiamine HCl Injection

Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.

Terminated Labeling / mix-up Mylan Institutional LLC D-0601-2021